Search

Search Constraints

You searched for: Author/Creator Gaba, L

Search Results

2. 13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC). (13th November 2020)

3. 17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial. (13th November 2020)

4. Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types. (27th August 2018)